Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
Clinical trial NCT05610891 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05610891
- Sponsor
- Cellectar Biosciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2026-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.